Loudness dependence of auditory evoked potentials (LDAEP) correlates with the availability of dopamine transporters and serotonin transporters in healthy volunteers - A two isotopes SPECT study

Psychopharmacology

Volumn 214, Issue 3, 2011, Pages 617-624

  Lee, I Hui ^a,b   Yang, Yen Kuang ^a,b   Chen, Po See ^a,b   Huang, Hui Chun ^a   Yeh, Tzung Lieh ^a,b   Lu, Ru Band ^a,b   Chiu, Nan Tsing ^b   Yao, Wei Jen ^b   Lin, Shih Hsien ^b  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Dopamine transporter; Event related evoked potential (ERP); Loudness dependence auditory evoked potentials (LDAEPs); Serotonin transporter; SPECT

Indexed keywords

[2 [[2 [[[3 (4 CHLOROPHENYL) 8 METHYL 8 AZABICYCLO[3.2.1]OCT 2 YL]METHYL](2 MERCAPTOETHYL)AMINO]ETHYL]AMINO]ETHANETHIOLATO]OXOTECHNETIUM TC 99M; ADAM I 123; DOPAMINE TRANSPORTER; IODINE 123; SEROTONIN TRANSPORTER; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; EVOKED AUDITORY RESPONSE; FEMALE; HUMAN; HUMAN EXPERIMENT; LOUDNESS DEPENDENCE AUDITORY EVOKED POTENTIAL; MALE; MESENCEPHALON; NEUROIMAGING; NORMAL HUMAN; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ACOUSTIC STIMULATION; ADULT; BRAIN; BRAIN MAPPING; CINANSERIN; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; EVOKED POTENTIALS, AUDITORY; FEMALE; HUMANS; LOUDNESS PERCEPTION; MALE; MIDDLE AGED; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; REGRESSION ANALYSIS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TROPANES; YOUNG ADULT;

EID: 79953651359     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-010-2064-8     Document Type: Article

References (59)

1. Berger B, Trottier S, Verney C, Gaspar P, Alvarez C (1988) Regional and laminar distribution of the dopamine and serotonin innervation in the macaque cerebral cortex: a radioautographic study. J Comp Neurol 273:99-119
2. Beucke JC, Uhl I, Plotkin M, Winter C, Assion HJ, Endrass T, Amthauer H, Kupsch A, Juckel G (2010) Serotonergic neurotransmission in early Parkinson's disease: a pilot study to assess implications for depression in this disorder. World J Biol Psychiatry 11:781-787
3. Bruneau N, Barthelemy C, Jouve J, Lelord G (1986) Frontal auditory-evoked potential augmenting-reducing and urinary homovanillic acid. Neuropsychobiology 16:78-84 (Pubitemid 17049764)
4. Carrillo-de-la-Pena MT, Mavrogiorgou P, Juckel G, Hauke W, Gallinat J, Frodl T, Zaudig M, Hegerl U (2000) Loudness dependence of auditory evoked potentials in obsessive-compulsive disorder: a pilot study. Psychiatry Res 93:209-216 (Pubitemid 30175951)
5. Catafau AM, Perez V, Penengo MM, Bullich S, Danus M, Puigdemont D, Pascual JC, Corripio I, Llop J, Perich J, Alvarez E (2005) SPECT of serotonin transporters using 123I-ADAM: optimal imaging time after bolus injection and long-term test-retest in healthy volunteers. J Nucl Med 46:1301-1309 (Pubitemid 43733479)
6. Chen PS, Yang YK, Yeh TL, Lee IH, Yao WJ, Chiu NT, Lu RB (2008) Correlation between body mass index and striatal dopamine transporter availability in healthy volunteers - a SPECT study. Neuroimage 40:275-279
7. Chou YH, Yang BH, Chung MY, Chen SP, Su TP, Chen CC, Wang SJ (2009) Imaging the serotonin transporter using (123)I-ADAM in the human brain. Psychiatry Res 172:38-43
8. Daumann J, Till B, Fischermann T, Rezk M, Gouzoulis-Mayfrank E (2006) Intensity dependence of auditory evoked dipole source activity in polydrug ecstasy users: evidence from an 18 months longitudinal study. J Psychopharmacol 20:236-244
9. Debener S, Strobel A, Kurschner K, Kranczioch C, Hebenstreit J, Maercker A, Beauducel A, Brocke B (2002) Is auditory evoked potential augmenting/reducing affected by acute tryptophan depletion? Biol Psychol 59:121-133
10. Gallinat J, Bottlender R, Juckel G, Munke-Puchner A, Stotz G, Kuss HJ, Mavrogiorgou P, Hegerl U (2000) The loudness dependency of the auditory evoked N1/P2-component as a predictor of the acute SSRI response in depression. Psychopharmacol Berl 148:404-411 (Pubitemid 30169759)
11. Guille V, Croft RJ, O'Neill BV, Illic S, Phan KL, Nathan PJ (2008) An examination of acute changes in serotonergic neurotransmission using the loudness dependence measure of auditory cortex evoked activity: effects of citalopram, escitalopram and sertraline. Hum Psychopharmacol 23:231-241 (Pubitemid 351577693)
12. Hegerl U, Juckel G (1993) Intensity dependence of auditory evoked potentials as an indicator of central serotonergic neurotransmission: a new hypothesis. Biol Psychiatry 33:173-187 (Pubitemid 23089966)
13. Hegerl U, Gallinat J, Juckel G (2001) Event-related potentials. Do they reflect central serotonergic neurotransmission and do they predict clinical response to serotonin agonists? J Affect Disord 62:93-100
14. Hensch T, Herold U, Diers K, Armbruster D, Brocke B (2008) Reliability of intensity dependence of auditory-evoked potentials. Clin Neurophysiol 119:224-236
15. Hesse S, Barthel H, Murai T, Muller U, Muller D, Seese A, Kluge R, Sabri O (2003) Is correction for age necessary in neuroimaging studies of the central serotonin transporter? Eur J Nucl Med Mol Imaging 30:427-430
16. Hochberg Y, Benjamini Y (1990) More powerful procedures for multiple significance testing. Stat Med 9:811-818 (Pubitemid 20343989)
17. Howell DC (2007) Statistical methods for psychology. Thomson Wadsworth, Belmont
18. Hwang WJ, Yao WJ, Wey SP, Ting G (2004) Reproducibility of 99mTc-TRODAT-1 SPECT measurement of dopamine transporters in Parkinson's disease. J Nucl Med 45:207-213 (Pubitemid 47618638)
19. Juckel G, Molnar M, Hegerl U, Csepe V, Karmos G (1997) Auditory-evoked potentials as indicator of brain serotonergic activity - first evidence in behaving cats. Biol Psychiatry 41:1181-1195 (Pubitemid 27237179)
20. Juckel G, Hegerl U, Giegling I, Mavrogiorgou P, Gallinat J, Augustin H, Mulert C, Pogarell O, Rujescu D (2007) Loudness dependence of auditory evoked potentials is not associated with polymorphisms or haplotypes in the serotonin transporter gene in a community-based sample of German healthy volunteers. Psychiatry Res 153:183-187 (Pubitemid 47539590)
21. Juckel G, Gudlowski Y, Muller D, Ozgurdal S, Brune M, Gallinat J, Frodl T, Witthaus H, Uhl I, Wutzler A, Pogarell O, Mulert C, Hegerl U, Meisenzahl EM (2008a) Loudness dependence of the auditory evoked N1/P2 component as an indicator of serotonergic dysfunction in patients with schizophrenia - a replication study. Psychiatry Res 158:79-82
22. Juckel G, Kawohl W, Giegling I, Mavrogiorgou P, Winter C, Pogarell O, Mulert C, Hegerl U, Rujescu D (2008b) Association of catechol-O- methyltransferase variants with loudness dependence of auditory evoked potentials. Hum Psychopharmacol Clin Exp 23:115-120 (Pubitemid 351359583)
23. Juckel G, Schumacher C, Giegling I, Assion HJ, Mavrogiorgou P, Pogarell O, Mulert C, Hegerl U, Norra C, Rujescu D (2010) Serotonergic functioning as measured by the loudness dependence of auditory evoked potentials is related to a haplotype in the brain-derived neurotrophic factor (BDNF) gene. J Psychiatr Res 44:541-546
24. Klein N, Sacher J, Geiss-Granadia T, Attarbaschi T, Mossaheb N, Lanzenberger R, Potzi C, Holik A, Spindelegger C, Asenbaum S, Dudczak R, Tauscher J, Kasper S (2006) In vivo imaging of serotonin transporter occupancy by means of SPECT and [123I] ADAM in healthy subjects administered different doses of escitalopram or citalopram. Psychopharmacol Berl 188:263-272
25. Kugaya A, Seneca NM, Snyder PJ, Williams SA, Malison RT, Baldwin RM, Seibyl JP, Innis RB (2003) Changes in human in vivo serotonin and dopamine transporter availabilities during chronic antidepressant administration. Neuropsychopharmacology 28:413-420
26. Lang UE, Hellweg R, Gallinat J (2005) Association of BDNF serum concentrations with central serotonergic activity: evidence from auditory signal processing. Neuropsychopharmacology 30:1148-1153 (Pubitemid 40720973)
27. Lee TW, Yu YW, Chen TJ, Tsai SJ (2005) Loudness dependence of the auditory evoked potential and response to antidepressants in Chinese patients with major depression. J Psychiatry Neurosci 30:202-205 (Pubitemid 40942459)
28. Lewis DA, Campbell MJ, Foote SL, Morrison JH (1986) The monoaminergic innervation of primate neocortex. Hum Neurobiol 5:181-188
29. Linka T, Muller BW, Bender S, Sartory G, Gastpar M (2005) The intensity dependence of auditory evoked ERP components predicts responsiveness to reboxetine treatment in major depression. Pharmacopsychiatry 38:139-143 (Pubitemid 40965968)
30. Linka T, Sartory G, Gastpar M, Scherbaum N, Muller BW (2009) Clinical symptoms of major depression are associated with the intensity dependence of auditory event-related potential components. Psychiatry Res 169:139-143 (Pubitemid 40965968)
31. Malison RT, Price LH, Berman R, van Dyck CH, Pelton GH, Carpenter L, Sanacora G, Owens MJ, Nemeroff CB, Rajeevan N, Baldwin RM, Seibyl JP, Innis RB, Charney DS (1998) Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 beta-carbomethoxy-3 beta-(4- iodophenyl)tropane and single photon emission computed tomography. Biol Psychiatry 44:1090-1098
32. Maswood S, Truitt W, Hotema M, Caldarola-Pastuszka M, Uphouse L (1999) Estrous cycle modulation of extracellular serotonin in mediobasal hypothalamus: role of the serotonin transporter and terminal autoreceptors. Brain Res 831:146-154 (Pubitemid 29336198)
33. Meyer JH (2007) Imaging the serotonin transporter during major depressive disorder and antidepressant treatment. J Psychiatry Neurosci 32:86-102
34. Meyer JH, Houle S, Sagrati S, Carella A, Hussey DF, Ginovart N, Goulding V, Kennedy J, Wilson AA (2004) Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes. Arch Gen Psychiatry 61:1271-1279 (Pubitemid 39602843)
35. Mitzdorf U (1994) Properties of cortical generators of event-related potentials. Pharmacopsychiatry 27:49-51
36. Mulert C, Juckel G, Brunnmeier M, Karch S, Leicht G, Mergl R, Moller HJ, Hegerl U, Pogarell O (2007) Prediction of treatment response in major depression: integration of concepts. J Affect Disord 98:215-225 (Pubitemid 46149060)
37. Nathan PJ, Segrave R, Phan KL, O'Neill B, Croft RJ (2006) Direct evidence that acutely enhancing serotonin with the selective serotonin reuptake inhibitor citalopram modulates the loudness dependence of the auditory evoked potential (LDAEP) marker of central serotonin function. Hum Psychopharmacol 21:47-52 (Pubitemid 43192475)
38. Norra C, Mrazek M, Tuchtenhagen F, Gobbele R, Buchner H, Sass H, Herpertz SC (2003) Enhanced intensity dependence as a marker of low serotonergic neurotransmission in borderline personality disorder. J Psychiatr Res 37:23-33 (Pubitemid 35449768)
39. Norra C, Becker S, Brocheler A, Kawohl W, Kunert HJ, Buchner H (2008) Loudness dependence of evoked dipole source activity during acute serotonin challenge in females. Hum Psychopharmacol 23:31-42 (Pubitemid 351166066)
40. O'Neill BV, Croft RJ, Leung S, Guille V, Galloway M, Phan KL, Nathan PJ (2006) Dopamine receptor stimulation does not modulate the loudness dependence of the auditory evoked potential in humans. Psychopharmacol Berl 188:92-99 (Pubitemid 44268245)
41. O'Neill BV, Croft RJ, Leung S, Oliver C, Phan KL, Nathan PJ (2007) High-dose glycine inhibits the loudness dependence of the auditory evoked potential (LDAEP) in healthy humans. Psychopharmacol Berl 195:85-93 (Pubitemid 47568619)
42. O'Neill BV, Croft RJ, Nathan PJ (2008a) The loudness dependence of the auditory evoked potential (LDAEP) as an in vivo biomarker of central serotonergic function in humans: rationale, evaluation and review of findings. Hum Psychopharmacol Clin Exp 23:355-370
43. O'Neill BV, Guille V, Croft RJ, Leung S, Scholes KE, Phan KL, Nathan PJ (2008b) Effects of selective and combined serotonin and dopamine depletion on the loudness dependence of the auditory evoked potential (LDAEP) in humans. Hum Psychopharmacol Clin Exp 23:301-312 (Pubitemid 351982667)
44. Pirker W, Asenbaum S, Hauk M, Kandlhofer S, Tauscher J, Willeit M, Neumeister A, Praschak-Rieder N, Angelberger P, Brucke T (2000) Imaging serotonin and dopamine transporters with 123I-beta-CIT SPECT: binding kinetics and effects of normal aging. J Nucl Med 41:36-44 (Pubitemid 30046682)
45. Pogarell O, Tatsch K, Juckel G, Hamann C, Mulert C, Popperl G, Folkerts M, Chouker M, Riedel M, Zaudig M, Moller HJ, Hegerl U (2004) Serotonin and dopamine transporter availabilities correlate with the loudness dependence of auditory evoked potentials in patients with obsessive-compulsive disorder. Neuropsychopharmacology 29:1910-1917 (Pubitemid 39336802)
46. Pogarell O, Juckel G, Norra C, Leicht G, Karch S, Schaaff N, Folkerts M, Ibrahim A, Mulert C, Hegerl U (2007a) Prediction of clinical response to antidepressants in patients with depression: neurophysiology in clinical practice. Clin EEG Neurosci 38:74-77 (Pubitemid 46866505)
47. Pogarell O, Koch W, Schaaff N, Popperl G, Mulert C, Juckel G, Moller HJ, Hegerl U, Tatsch K (2007b) [I-123] ADAM brainstem binding correlates with the loudness dependence of auditory evoked potentials. Eur Arch Psychiatry Clin Neurosci 258:40-47 (Pubitemid 351208248)
48. Roser P, Della B, Norra C, Juckel G, Uhl I (2009) No association between chronic cannabis use and loudness dependence of auditory evoked potentials as indicator of central serotonergic neurotransmission. Neurosci Lett 465:113-117
49. Seamans JK, Yang CR (2004) The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog Neurobiol 74:1-58
50. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC (1998) The Mini- International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59(Suppl 20):22-33, quiz 34-57
51. Staley JK, Basile M, Flynn DD, Mash DC (1994) Visualizing dopamine and serotonin transporters in the human brain with the potent cocaine analogue [125I]RTI-55: in vitro binding and autoradiographic characterization. J Neurochem 62:549-556
52. Strobel A, Debener S, Schmidt D, Hunnerkopf R, Lesch KP, Brocke B (2003) Allelic variation in serotonin transporter function associated with the intensity dependence of the auditory evoked potential. Am J Med Genet B Neuropsychiatr Genet 118B:41-47 (Pubitemid 37064074)
53. Tabachnick BG, Fidell LS (2007) Using multivariate statistics. Allyn and Bacon, Boston
54. Takeuchi Y, Sano Y (1983) Immunohistochemical demonstration of serotonin nerve fibers in the neocortex of the monkey (Macaca fuscata). Anat Embryol (Berl) 166:155-168 (Pubitemid 13137706)
55. Uhl I, Gorynia I, Gallinat J, Mulert C, Wutzler A, Heinz A, Juckel G (2006) Is the loudness dependence of auditory evoked potentials modulated by the selective serotonin reuptake inhibitor citalopram in healthy subjects? Hum Psychopharmacol 21:463-471
56. Volkow ND, Wang GJ, Telang F, Fowler JS, Thanos PK, Logan J, Alexoff D, Ding YS, Wong C, Ma Y, Pradhan K (2008) Low dopamine striatal D2 receptors are associated with prefrontal metabolism in obese subjects: possible contributing factors. Neuroimage 42:1537-1543
57. Wutzler A, Winter C, Kitzrow W, Uhl I, Wolf RJ, Heinz A, Juckel G (2008) Loudness dependence of auditory evoked potentials as indicator of central serotonergic neurotransmission: simultaneous electrophysiological recordings and in vivo microdialysis in the rat primary auditory cortex. Neuropsychopharmacology 33:3176-3181
58. Yang YK, Yao WJ, Yeh TL, Lee IH, Chen KC, Lu RB (2007) Association between serotonin transporter availability and hostility scores in healthy volunteers - a single photon emission computed tomography study with [(123)I] ADAM. Psychiatry Res 154:281-284
59. Yeh TL, Lee IH, Chen KC, Chen PS, Yao WJ, Yang YK, Chiu NT, Lu RB (2009) The relationships between daily life events and the availabilities of serotonin transporters and dopamine transporters in healthy volunteers - a dual-isotope SPECT study. Neuroimage 45:275-279